Robert M. Turner, II, MD
RCC: Multiple pathways provide therapeutic targets
Read highlights from a presentation by Toni K. Choueiri, MD, at the Society of Urologic Oncology annual meeting.
High-grade bladder Ca: New data improve risk stratification
“We need to identify those patients with high-grade T1 bladder cancer that are likely to recur or progress… and find additional options to prevent recurrence and progression in these patients,” said Joaquim Bellmunt, MD, PhD, in a presentation at the SUO annual meeting.
How surgical coaching helps performance, outcomes
UT SUO internship program member Robert M. Turner, II, MD, reports on a recent keynote addressing current coaching initiatives and their impact on outcomes.
How renal mass biopsy impacts management
Urology Times SUO internship program member Robert M. Turner, II, MD, reports on a recent presentation by J. Stuart Wolf, Jr., MD, about possible pitfalls of renal mass biopsy.

Poll